Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis

Luca Laurenti, MD, Barbara Vannata, Idanna Innocenti, Francesco Autore, MD, Francesco Santini, Federica Sorà, Tommaso Za, Sara Marietti, Silvia Bellesi, Simona Sica, MD, Dimitar G Efremov, MD, PhD, Giuseppe Leone

Blood (2012) 120 (21): 4604.

https://doi.org/10.1182/blood.V120.21.4604.4604

Published: 2012

Journal Articles

Age Influences Initial Dose and Compliance to Imatinib In Chronic Myeloid Leukemia Elederly Patients but Concomitant Comorbidities Appear to Influence Overall and Event-Free Survival

Blood (2011) 118 (21): 2751.

https://doi.org/10.1182/blood.V118.21.2751.2751

Published: 2011

Journal Articles

Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies

Blood (2011) 118 (21): 112.

https://doi.org/10.1182/blood.V118.21.112.112

Published: 2011

Journal Articles

Moderate/ Severe Pleural Effusion As a Side Effect in Very Old Chronic Myeloid Leukemia (CML) Patients Undergoing Imatinib Treatment

Blood (2011) 118 (21): 4445.

https://doi.org/10.1182/blood.V118.21.4445.4445

Published: 2011

Journal Articles

Hammersmith Score Is Able to Identify Chronic Myeloid Leukemia Patients with Poor Prognosis Before Treatment with Second-Generation TKIs.

Massimo Breccia, Roberto Latagliata, MD, Fabio Stagno, Antonella Gozzini, Elisabetta Abruzzese, Antonella Russo Rossi, Michelina Santopietro, Laura Cannella, Federica Sorà, Paolo Vigneri, Malgorzata Trawinska, Simona Sica, Giorgina Specchia, Valeria Santini, MD, Giuliana Alimena

Blood (2010) 116 (21): 3409.

https://doi.org/10.1182/blood.V116.21.3409.3409

Published: 2010

Journal Articles

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Blood (2010) 116 (21): 3460.

https://doi.org/10.1182/blood.V116.21.3460.3460

Published: 2010

Journal Articles

Imatinib In Very Elderly CML Patients: What Can We Achieve?.

Blood (2010) 116 (21): 1229.

https://doi.org/10.1182/blood.V116.21.1229.1229

Published: 2010

Journal Articles

Retrospective Application of European LeukemiaNet Provisional Criteria for Second-Generation TKI Chronic Myeloid Leukemia

Massimo Breccia, Roberto Latagliata, MD, Fabio Stagno, Antonella Gozzini, Elisabetta Abruzzese, Francesco Albano, Vincenzo Federico, Federica Sorà, Paolo Vigneri, Giuseppina Loglisci, Malgorzata Trawinska, Simona Sica, Giorgina Specchia, Valeria Santini, MD, Giuliana Alimena

Blood (2010) 116 (21): 2270.

https://doi.org/10.1182/blood.V116.21.2270.2270

Published: 2010

Journal Articles

Bcr-Abl Kinase Domain Mutations in Imatinib and in Second-Generation Tyrosine Kinase Inhibitor Eras: Seven Years of Mutation Analysis, a Report by the GIMEMA CML Working Party

Blood (2010) 116 (21): 2279.

https://doi.org/10.1182/blood.V116.21.2279.2279

Published: 2010

Journal Articles

SDF1 Plasma Levels and CD34+ Cells Recirculation After Autologous Peripheral Blood Stem Cell Transplant.

Nicola Piccirillo, Giuseppe Ausoni, Silvia De Matteis, Luca Laurenti, MD, Patrizia Chiusolo, Federica Sorà, Giuseppe d'Onofrio, Giuseppe Leone, Simona Sica

Blood (2009) 114 (22): 4571.

https://doi.org/10.1182/blood.V114.22.4571.4571

Published: 2009

Journal Articles

Reliability of Leukostasis Grading Score to Identify High Risk Patients with Hyperleukocytic Leukemia

Nicola Piccirillo, MD, Luca Laurenti, MD, Patrizia Chiusolo, MD, Federica Sorà, MD, Maria Bianchi, MD, Silvia De Matteis, MD, Livio Pagano, MD, Gina Zini, MD, Giuseppe d’Onofrio, MD, Giuseppe Leone, MD, Simona Sica, MD

Blood (2008) 112 (11): 2979.

https://doi.org/10.1182/blood.V112.11.2979.2979

Published: 2008

Journal Articles

The Use of Low-Dose Alemtuzumab as Single Agent in the Treatment of Complication in Advanced Chronic Lymphocytic Leukaemia

Luca Laurenti, MD, Michela Tarnani, Idanna Innocenti, Silvia De Matteis, Simona Sica, Federica Sorà, Patrizia Chiusolo, Dimitar Efremov, MD, PhD, Sara Marietti, Giuseppe Leone

Blood (2008) 112 (11): 4212.

https://doi.org/10.1182/blood.V112.11.4212.4212

Published: 2008

Journal Articles

A New Method To Evaluate the Prognostic Value of Response to Prednisone Pre-Treatment in Adult (15–60 Yrs) Patients with Acute Lymphoblastic Leukemia: Results of the GIMEMA LAL 2000 Study.

Giovanna Meloni, MD, Simona Iacobelli, PhD, Paola Fazi, MD, Marco Vignetti, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Vincenzo Liso, MD, Salvatore Mirto, MD, Giuseppe Fioritoni, MD, Alessandra Tedeschi, MD, Giuseppe Torelli, MD, Federica Sorà, MD, Federico Mosna, MD, Ciro Rinaldi, MD, Francesco Nobile, MD, Robert Foà, MD, Franco Mandelli, MD

Blood (2005) 106 (11): 1829.

https://doi.org/10.1182/blood.V106.11.1829.1829

Published: 2005

Journal Articles

Peg-Filgrastim after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Hematological Malignancies: A Matched-Pair Analysis.

Simona Sica, Nicola Piccirillo, Silvia De Matteis, Luca Laurenti, Patrizia Chiusolo, Serena De Vita, Federica Sorà, Rossana Putzulu, Giovanni Reddiconto, Giuliana Farina, Giuseppe d’Onofrio, Giuseppe Leone

Blood (2004) 104 (11): 5035.

https://doi.org/10.1182/blood.V104.11.5035.5035

Published: 2004

NARROW

Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis

Age Influences Initial Dose and Compliance to Imatinib In Chronic Myeloid Leukemia Elederly Patients but Concomitant Comorbidities Appear to Influence Overall and Event-Free Survival

Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies

Moderate/ Severe Pleural Effusion As a Side Effect in Very Old Chronic Myeloid Leukemia (CML) Patients Undergoing Imatinib Treatment

Hammersmith Score Is Able to Identify Chronic Myeloid Leukemia Patients with Poor Prognosis Before Treatment with Second-Generation TKIs.

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Imatinib In Very Elderly CML Patients: What Can We Achieve?.

Retrospective Application of European LeukemiaNet Provisional Criteria for Second-Generation TKI Chronic Myeloid Leukemia

Bcr-Abl Kinase Domain Mutations in Imatinib and in Second-Generation Tyrosine Kinase Inhibitor Eras: Seven Years of Mutation Analysis, a Report by the GIMEMA CML Working Party

SDF1 Plasma Levels and CD34+ Cells Recirculation After Autologous Peripheral Blood Stem Cell Transplant.

Reliability of Leukostasis Grading Score to Identify High Risk Patients with Hyperleukocytic Leukemia

The Use of Low-Dose Alemtuzumab as Single Agent in the Treatment of Complication in Advanced Chronic Lymphocytic Leukaemia

A New Method To Evaluate the Prognostic Value of Response to Prednisone Pre-Treatment in Adult (15–60 Yrs) Patients with Acute Lymphoblastic Leukemia: Results of the GIMEMA LAL 2000 Study.

Peg-Filgrastim after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Hematological Malignancies: A Matched-Pair Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only